StockTipsArenaBeta

Abbott India Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹25,680-225.00 (-0.87%)
As of 21 Oct 2026

Avg 1-year target

All 7 long-term calls are BUY

₹31,619.523.1% above today's price

Abbott India's average 1-year share price target is ₹31,619.5, the average of 2 advisors' latest targets. Targets range from ₹30,839 to ₹32,400.

Latest: BOB Capital Markets ₹30,839 · 3 Sept 2026

7
7 BUY · 0 SELL, all horizons
2
with an active 1Y target
60%
9 of 15 closed calls hit
22
all horizons, open and closed
Watch ABBOTINDIA for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Abbott India target price by brokerage

Each advisor's latest 1-year target · 2 advisors · tap a row for the call

All tips (22)

BUYTarget₹30,839
BCbyBOB Capital Markets+20.1% to target
1 Year* · 11 mo left · 3 Sept 2026 · entry ₹25,945 · via Institutional / Brokerage ResearchP&L -1.0%
BUYTarget₹36,457
BCbyBOB Capital Markets+42.0% to target
1 Year* · 7 mo left · 13 May 2026 · entry ₹27,280 · via Institutional / Brokerage ResearchP&L -5.9%
BUYTarget₹32,400
ISbyICICI Securities+26.2% to target
1 Year* · 7 mo left · 12 May 2026 · entry ₹26,900 · via Institutional / Brokerage ResearchP&L -4.5%
BUYTarget₹32,150
ISbyICICI Securities+25.2% to target
1 Year* · 4 mo left · 13 Feb 2026 · entry ₹26,460 · via Institutional / Brokerage ResearchP&L -2.9%
BUYTarget₹34,500
ISbyICICI Securities+34.3% to target
1 Year* · 3 wk left · 9 Nov 2025 · entry ₹28,785 · via Institutional / Brokerage ResearchP&L -10.8%
BUYTarget₹33,550
ISbyICICI Securities+30.6% to target
1 Year* · 2 wk left · 8 Nov 2025 · entry ₹28,785 · via Institutional / Brokerage ResearchP&L -10.8%
BUYTarget₹40,000
BCbyBOB Capital Markets+55.8% to target
1 Year* · 2 wk left · 7 Nov 2025 · entry ₹28,785 · via Institutional / Brokerage ResearchP&L -10.8%
BUYTarget₹35,750
ISbyICICI SecuritiesTarget hit
1 Year* · 16 May 2025 · entry ₹30,560 · via Institutional / Brokerage Researchexit ₹35,750
BUYTarget₹35,292
BCbyBOB Capital MarketsTarget hit
1 Year* · 11 Apr 2025 · entry ₹29,641.1 · via Institutional / Brokerage Researchexit ₹35,292
BUYTarget₹32,700
ISbyICICI SecuritiesTarget hit
1 Year* · 6 Feb 2025 · entry ₹29,081.1 · via Institutional / Brokerage Researchexit ₹32,700
BUYTarget₹31,420
ASbyAxis SecuritiesTarget hit
1 Year* · 26 Oct 2024 · entry ₹28,509.1 · via Institutional / Brokerage Researchexit ₹31,420
BUYTarget₹32,000
SRbySharekhan ResearchTarget hit
1 Year* · 8 Aug 2024 · entry ₹27,219.7 · via Institutional / Brokerage Researchexit ₹32,000
BUYTarget₹31,000
ASbyAxis SecuritiesTarget hit
1 Year* · 8 Aug 2024 · entry ₹27,219.7 · via Institutional / Brokerage Researchexit ₹31,000
BUYTarget₹28,500
ASbyAxis SecuritiesTarget hit
1 Year* · 10 May 2024 · entry ₹26,370.5 · via Institutional / Brokerage Researchexit ₹28,500
BUYTarget₹30,540
SRbySharekhan ResearchTarget hit
1 Year* · 9 May 2024 · entry ₹25,562.4 · via Institutional / Brokerage Researchexit ₹30,540
BUYTarget₹28,400
ASbyAxis SecuritiesTarget hit
1 Year* · 2 Feb 2024 · entry ₹28,064.3 · via Institutional / Brokerage Researchexit ₹28,400
BUYTarget₹34,470
SRbySharekhan ResearchExpired
1 Year* · 17 Sept 2025 · entry ₹30,970 · via Institutional / Brokerage Researchexit ₹26,125
BUYTarget₹39,148
BCbyBOB Capital MarketsExpired
1 Year* · 12 Aug 2025 · entry ₹32,560 · via Institutional / Brokerage Researchexit ₹28,020
BUYTarget₹40,128
BCbyBOB Capital MarketsExpired
1 Year* · 4 Jul 2025 · entry ₹34,735 · via Institutional / Brokerage Researchexit ₹25,895
BUYTarget₹32,500
ISbyICICI SecuritiesExpired
1 Year* · 12 May 2024 · entry ₹26,370.5 · via Institutional / Brokerage Researchexit ₹30,065
BUYTarget₹30,950
AJbyAnsh Jogendra BhilwarStop-loss hit
1–3 Months* · 13 Aug 2026 · entry ₹28,610 · via Zee Business (Live)exit ₹26,730
BUYTarget₹26,500
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 15 Sept 2026 · entry ₹26,122.3 · via CNBC Awaaz.exit ₹26,000

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks